BT061

BIOLOGICAL2 trials

Sponsors

Biotest

Conditions

Psoriasis VulgarisRheumatoid Arthritis

Phase 2

Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis

CompletedNCT01072383

BiotestPsoriasis Vulgaris

Start: 2010-02-28End: 2011-08-31Updated: 2012-03-13

Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)

CompletedNCT01481493

BiotestRheumatoid Arthritis

Start: 2010-12-31End: 2013-11-30Updated: 2015-02-20